MEDFORD, N.Y., June 4, 2014 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq:CEMI), a leader in point-of-care (POC) diagnostic tests and technology, today announced the launch of the Company's U.S. sales and marketing effort. Effective today, the Company has initiated sales of its Chembio HIV 1/2 STAT-PAK® Assay and its corresponding HIV Rapid Test Control Pack, as well as the Company's proprietary DPP® HIV 1/2 Assay and corresponding DPP® HIV 1/2 Control Pack in the United States. The Company has also assumed all customer and technical support for its Chembio-branded products in the U.S.
Help employers find you! Check out all the jobs and post your resume.
